glp-1 agonist drug interactions receptor agonists show promise in treating substance use disorders Emerging Frontiers in GLP-1 Therapeutics:

194 of those patients were taking semaglutide versus 516 who were on non-GLP-1 RA medications

Obesity (Silver Spring) 2020;28:529536

Outside of the fat loss, there were a few days where I may have dosed too high and I was forcefeeding to hit my protein and 1600 to 1900 calories

Through leave-one-out sensitivity testing, we confirmed that our findings were stable and not driven by any single study

There have been several head-to-head clinical trials comparing the efficacy of different GLP-1 receptor agonists broadly demonstrating the superiority of semaglutide to comparators [37]

At the same time, the data imply that a medicinal chemistry campaign focusing on engineering pharmacokinetically optimized GLP-1MK-801 conjugates might give rise to drugs that could outperform the current incretin-based treatments for obesity, such as semaglutide and tirzepatide